cd47-targeting antibody: targeting the source of non-hodgkin lymphoma
Published 5 years ago • 1.6K plays • Length 3:11Download video MP4
Download video MP3
Similar videos
-
1:18
the mechanism of action of anti-cd47 antibodies & where these may fit in the mds treatment landscape
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
2:08
cellular and targeted therapies for hodgkin lymphoma
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
4:23
chartese, non-hodgkin lymphoma survivor
-
3:57
cd47 antibody treatment shrinks or eliminates human cancer tumors in mice
-
46:21
diapath - webinar - quality control in immunohistochemistry
-
1:06
dose escalation of the anti-cd47 tti-622 in nhl
-
2:36
a cd38-targeting bispecific antibody in the treatment of r/r t-all
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
2:15
vipor: a multi-targeted therapy for the treatment of r/r dlbcl
-
2:28
tackling cd47-positive malignancies
-
2:15
cd47-blocking checkpoint inhibitor tti-621 shows promising results for cutaneous t-cell lymphomas
-
1:52
targeting cd74 in b-cell non-hodgkin lymphoma with antibody-drug conjugate stro-001 | oncotarget
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:56
optimal therapy sequencing for hodgkin lymphoma
-
1:37
the role of ctdna in hodgkin lymphoma
-
6:38
the sequencing of cd19-targeting car-ts and cd20-targeting bispecifics in dlbcl
-
2:56
immuno-oncology opportunities for the treatment of lymphoma
-
3:49
cd47 discovery: flipping the script on cancer | stanford cancer institute
-
4:06
lymphoma cellular therapy update